Evaluating Nephrocheck
IGFBP-7
KIM-1
L-FABP
NGAL
TIMP-2
interleukin-18
Journal
International journal of nephrology and renovascular disease
ISSN: 1178-7058
Titre abrégé: Int J Nephrol Renovasc Dis
Pays: New Zealand
ID NLM: 101550217
Informations de publication
Date de publication:
2020
2020
Historique:
received:
30
11
2019
accepted:
01
04
2020
entrez:
20
5
2020
pubmed:
20
5
2020
medline:
20
5
2020
Statut:
epublish
Résumé
Acute kidney injury (AKI) is a common complication in critically ill patients in the intensive settings with increased risks of short- and long-term complications and mortality. AKI is also associated with an increased length of stay in intensive care units (ICU) and worse kidney function recovery at hospital discharge. The management of AKI is one of the major challenges for nephrologists and intensivists overall for its early diagnosis. The current KDIGO criteria used to define AKI include the serum creatinine and urinary output that are neither sensitive nor specific markers of kidney function, since they can be altered only after hours from the kidney injury. In order to allow an early AKI detection, in the last years, several studies focused on the identification of new biomarkers. Among all these markers, urinary insulin-like growth factor-binding protein (IGFBP-7) and tissue inhibitor of metalloproteinase (TIMP-2) have been proven as the best-performing and have been proposed as a predictive tool for the AKI detection in the critical settings in order to perform an early diagnosis. Patients undergoing major surgery, cardiac surgery, those with hemodynamic instability or those with sepsis are believed to be the top priority patient populations for the biomarker test. In this view, the urinary [TIMP-2] x [IGFBP-7] becomes an important tool for the early detection of patients at high risk for AKI and its integration with the local ICU experience has to provide a multidisciplinary management of AKI with the institution of a rapid response team in order to assess patients and customize AKI management.
Identifiants
pubmed: 32425580
doi: 10.2147/IJNRD.S198222
pii: 198222
pmc: PMC7189184
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
85-96Informations de copyright
© 2020 Nalesso et al.
Déclaration de conflit d'intérêts
Financial support: no grants or funding have been received for this study. The authors report no conflicts of interest in this work.
Références
JAMA. 2005 Aug 17;294(7):813-8
pubmed: 16106006
Crit Care. 2013 Feb 06;17(1):R25
pubmed: 23388612
Crit Care. 2016 Jul 07;20(1):201
pubmed: 27384344
J Cardiothorac Vasc Anesth. 2016 Jan;30(1):82-9
pubmed: 26482484
Transplant Proc. 2017 Nov;49(9):2050-2054
pubmed: 29149959
Crit Care. 2019 May 8;23(1):163
pubmed: 31068215
Crit Care. 2019 Feb 14;23(1):48
pubmed: 30764856
Crit Care. 2014 Nov 20;18(6):606
pubmed: 25673427
Blood Purif. 2017;43(1-3):82-88
pubmed: 27915329
Ann Thorac Surg. 2018 Apr;105(4):1094-1101
pubmed: 29382510
Cardiorenal Med. 2019;9(6):358-369
pubmed: 31618746
PLoS One. 2015 Mar 23;10(3):e0120863
pubmed: 25798585
Ann Intensive Care. 2017 Sep 7;7(1):92
pubmed: 28884304
Crit Care. 2012 Jun 21;16(3):313
pubmed: 22721504
Int J Artif Organs. 2019 Nov;42(11):665-667
pubmed: 31151359
J Cardiothorac Vasc Anesth. 2017 Dec;31(6):2072-2079
pubmed: 28803769
JAMA Intern Med. 2020 Jan 27;:
pubmed: 31985750
Int J Nephrol Renovasc Dis. 2017 Jun 28;10:175-181
pubmed: 28721084
Shock. 2014 Jan;41(1):3-11
pubmed: 24346647
Cardiorenal Med. 2019;9(6):354-357
pubmed: 31618745
J Am Heart Assoc. 2018 Jun 1;7(11):
pubmed: 29858368
Intensive Care Med. 2017 Nov;43(11):1551-1561
pubmed: 28110412
Methods Mol Biol. 2014;1170:29-40
pubmed: 24906307
J Thorac Cardiovasc Surg. 2019 Apr;157(4):1545-1553.e5
pubmed: 30389130
Int Urol Nephrol. 2017 Jun;49(6):1041-1047
pubmed: 28255639
Contrib Nephrol. 2016;188:1-10
pubmed: 27169469
Intensive Care Med. 2015 Aug;41(8):1411-23
pubmed: 26162677
PLoS One. 2014 Mar 27;9(3):e93460
pubmed: 24675717
Contrib Nephrol. 2016;188:11-20
pubmed: 27169556
Crit Care. 2017 Apr 11;21(1):92
pubmed: 28395664
BMC Cancer. 2019 Nov 8;19(1):1066
pubmed: 31703649
Resuscitation. 2019 Aug;141:104-110
pubmed: 31216431
Am J Kidney Dis. 2016 Jul;68(1):19-28
pubmed: 26948834
Kidney Blood Press Res. 2017 Jul 27;42(3):456-467
pubmed: 28750409
Korean J Intern Med. 2020 May;35(3):662-671
pubmed: 31856559
Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3534-3543
pubmed: 29917208
Crit Care. 2018 May 12;22(1):126
pubmed: 29751827
Nefrologia. 2018 Jul - Aug;38(4):361-367
pubmed: 29627229
Dis Markers. 2019 Apr 1;2019:3471215
pubmed: 31061681
Semin Nephrol. 2012 Jan;32(1):18-25
pubmed: 22365158
Int J Artif Organs. 2017 Nov 24;40(12):714-718
pubmed: 29148021
Blood Purif. 2018;45(1-3):270-277
pubmed: 29478052
Clin Chem Lab Med. 2017 Jul 26;55(8):1074-1089
pubmed: 28076311
Biomed Res Int. 2018 Apr 24;2018:6937947
pubmed: 29854781
Crit Care. 2016 Oct 5;20(1):314
pubmed: 27716377
Lancet. 2005 Apr 2-8;365(9466):1231-8
pubmed: 15811456
Clin Cardiol. 2017 Jul;40(7):485-491
pubmed: 28295429
Kidney Int. 2013 Sep;84(3):457-67
pubmed: 23636171
Nephrol Dial Transplant. 2010 May;25(5):1416-20
pubmed: 20228069
Front Physiol. 2016 Jul 06;7:286
pubmed: 27458386
Nat Med. 2010 May;16(5):535-43, 1p following 143
pubmed: 20436483
Transpl Int. 2018 Jul;31(7):751-760
pubmed: 29505681
Crit Care. 2004 Aug;8(4):R204-12
pubmed: 15312219
JAMA. 2017 Nov 14;318(18):1787-1797
pubmed: 29136443
Crit Care. 2019 Jun 20;23(1):225
pubmed: 31221200
Kidney Int. 2014 Mar;85(3):513-21
pubmed: 24107851
Crit Care Med. 2016 Oct;44(10):1851-60
pubmed: 27355527
Contrib Nephrol. 2016;188:21-32
pubmed: 27169621
Crit Care. 2015 Jan 06;19:3
pubmed: 25560277
Thorac Cardiovasc Surg. 2019 Feb 11;:
pubmed: 30743275
Nephrol Dial Transplant. 2019 Feb 1;34(2):308-317
pubmed: 30053231
Nat Rev Nephrol. 2012 Dec;8(12):735-9
pubmed: 23007617
Clin Chem Lab Med. 2019 Apr 24;57(5):567-576
pubmed: 30179848
Transplantation. 2019 May;103(5):1014-1023
pubmed: 30300282
Anaesth Crit Care Pain Med. 2018 Aug;37(4):335-341
pubmed: 29777769
Transpl Int. 2015 Dec;28(12):1392-404
pubmed: 26174580